Clinical trial
RRA-18896: An Observational Study to Assess the Long-term Safety of Ustekinumab Versus Other Biologic Therapies Among Patients With Crohn's Disease: A New-User Cohort Study Using the Department of Defense Electronic Health Records Database
NCT04372108 is registered in ClinicalTrials.gov with Janssen Scientific Affairs, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RRA-18896: An Observational Study to Assess the Long-term Safety of Ustekinumab Versus Other Biologic Therapies Among Patients With Crohn's Disease: A New-User Cohort Study Using the Department of Defense Electronic Health Records Database
- Lead sponsor
- Janssen Scientific Affairs, LLC
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 24, 2021
- Completion date
- August 30, 2030
- Enrollment
- 1,536 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.